These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15320777)

  • 21. K(ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect.
    Lawrence KM; Chanalaris A; Scarabelli T; Hubank M; Pasini E; Townsend PA; Comini L; Ferrari R; Tinker A; Stephanou A; Knight RA; Latchman DS
    Circulation; 2002 Sep; 106(12):1556-62. PubMed ID: 12234964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.
    Pedersen WA; Wan R; Zhang P; Mattson MP
    J Neurosci; 2002 Jan; 22(2):404-12. PubMed ID: 11784785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotective Utility of Urocortin in Myocardial Ischemia- Reperfusion Injury: Where do We Stand?
    Basman C; Agrawal P; Knight R; Saravolatz L; McRee C; Chen-Scarabelli C; Narula J; Scarabelli T
    Curr Mol Pharmacol; 2018; 11(1):32-38. PubMed ID: 28228090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urocortin: a cardiac protective peptide?
    Tao J; Li S
    Biochem Biophys Res Commun; 2005 Jul; 332(4):923-6. PubMed ID: 15949465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urocortin and corticotropin-releasing hormone receptor type 2 expression in the human gallbladder.
    Chatzaki E; Euthymiadis C; Kyriaki S; Lambropoulou M; Tsaroucha A; Laftsidis P; Simopoulos K
    Neuroendocrinology; 2005; 82(3-4):177-84. PubMed ID: 16534239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urocortin does not reduce the renal injury and dysfunction caused by experimental ischaemia/reperfusion.
    Patel NS; Collin M; Thiemermann C
    Eur J Pharmacol; 2004 Aug; 496(1-3):175-80. PubMed ID: 15288588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortins in human reproduction.
    Florio P; Vale W; Petraglia F
    Peptides; 2004 Oct; 25(10):1751-7. PubMed ID: 15476942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.
    Wiley KE; Davenport AP
    Br J Pharmacol; 2004 Oct; 143(4):508-14. PubMed ID: 15381637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
    Coste SC; Kesterson RA; Heldwein KA; Stevens SL; Heard AD; Hollis JH; Murray SE; Hill JK; Pantely GA; Hohimer AR; Hatton DC; Phillips TJ; Finn DA; Low MJ; Rittenberg MB; Stenzel P; Stenzel-Poore MP
    Nat Genet; 2000 Apr; 24(4):403-9. PubMed ID: 10742107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart.
    Coste SC; Heldwein KA; Stevens SL; Tobar-Dupres E; Stenzel-Poore MP
    Endocrinology; 2001 Aug; 142(8):3537-45. PubMed ID: 11459800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection.
    Yuan Z; McCauley R; Chen-Scarabelli C; Abounit K; Stephanou A; Barry SP; Knight R; Saravolatz SF; Saravolatz LD; Ulgen BO; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Scarabelli TM
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):1-7. PubMed ID: 20416357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Urocortins: mechanisms of cardioprotection and therapeutic potential.
    Lawrence KM; Latchman DS
    Mini Rev Med Chem; 2006 Oct; 6(10):1119-26. PubMed ID: 17073712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and protective effects of urocortin in cardiac myocytes.
    Okosi A; Brar BK; Chan M; D'Souza L; Smith E; Stephanou A; Latchman DS; Chowdrey HS; Knight RA
    Neuropeptides; 1998 Apr; 32(2):167-71. PubMed ID: 9639256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion.
    Scarabelli TM; Pasini E; Stephanou A; Comini L; Curello S; Raddino R; Ferrari R; Knight R; Latchman DS
    J Am Coll Cardiol; 2002 Jul; 40(1):155-61. PubMed ID: 12103270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urocortin 2 in cardiovascular health and disease.
    Adão R; Santos-Ribeiro D; Rademaker MT; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2015 Jul; 20(7):906-14. PubMed ID: 25748088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urocortin protects coronary endothelial function during ischemia-reperfusion: a brief communication.
    García-Villalón AL; Sanz E; Monge L; Fernández N; Climent B; Diéguez G
    Exp Biol Med (Maywood); 2004 Jan; 229(1):118-20. PubMed ID: 14709784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotective action of urocortin in early pre- and postconditioning.
    Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
    Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response.
    Baigent SM
    Peptides; 2001 May; 22(5):809-20. PubMed ID: 11337095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism.
    Linthorst AC; Peñalva RG; Flachskamm C; Holsboer F; Reul JM
    Eur J Neurosci; 2002 Dec; 16(12):2441-52. PubMed ID: 12492439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.